Centrus Energy Reports Decline in Q1 Profit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy LEU?
Source: NASDAQ.COM
- Profit Decline: Centrus Energy reported a first-quarter net profit of $10 million, or $0.45 per share, which represents a significant drop from last year's $27.2 million and $1.60 per share, indicating a notable weakening in the company's profitability.
- Adjusted Earnings: Excluding special items, Centrus reported adjusted earnings of $23.5 million, or $1.05 per share, which, while lower than last year, still demonstrates some resilience in earnings performance amidst challenging conditions.
- Revenue Growth: The company's revenue for the first quarter rose by 4.9% to $76.7 million, up from $73.1 million last year, suggesting that the business has managed to maintain a degree of growth despite the profit decline.
- Full-Year Revenue Guidance: Centrus has provided full-year revenue guidance of $450 million to $500 million, reflecting a cautiously optimistic outlook for future revenue growth, despite the current profit decline, indicating management's confidence in market demand.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy LEU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on LEU
Wall Street analysts forecast LEU stock price to rise
14 Analyst Rating
10 Buy
4 Hold
0 Sell
Moderate Buy
Current: 206.300
Low
117.00
Averages
297.10
High
390.00
Current: 206.300
Low
117.00
Averages
297.10
High
390.00
About LEU
Centrus Energy Corp. is a supplier of nuclear fuel components for the nuclear power industry. Its segments include Low-Enriched Uranium (LEU) and Technical Solutions. Its LEU segment supplies various components of nuclear fuel to commercial customers from its global network of suppliers. The LEU segment consists of two components: SWU and natural uranium hexafluoride. It supplies LEU and its components to both domestic and international utilities for use in nuclear reactors worldwide. It provides LEU from multiple sources, including its inventory, medium- and long-term supply contracts, and spot purchases. It also sells natural uranium hexafluoride and occasionally sells uranium concentrates. The Technical Solutions segment provides advanced engineering, design, and manufacturing services to government and private sector customers. It is deploying uranium enrichment and other capabilities necessary to produce advanced nuclear fuel to power existing reactors around the world.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Centrus Energy Reports Decline in Q1 Profit
- Profit Decline: Centrus Energy reported a first-quarter net profit of $10 million, or $0.45 per share, which represents a significant drop from last year's $27.2 million and $1.60 per share, indicating a notable weakening in the company's profitability.
- Adjusted Earnings: Excluding special items, Centrus reported adjusted earnings of $23.5 million, or $1.05 per share, which, while lower than last year, still demonstrates some resilience in earnings performance amidst challenging conditions.
- Revenue Growth: The company's revenue for the first quarter rose by 4.9% to $76.7 million, up from $73.1 million last year, suggesting that the business has managed to maintain a degree of growth despite the profit decline.
- Full-Year Revenue Guidance: Centrus has provided full-year revenue guidance of $450 million to $500 million, reflecting a cautiously optimistic outlook for future revenue growth, despite the current profit decline, indicating management's confidence in market demand.
See More
Centrus Energy Corp. Q1 2026 Earnings Call Highlights
- Historic Expansion Launch: Centrus initiated its historic project to return the U.S. to domestic commercial uranium enrichment in Q1 2026, with CEO Amir Vexler emphasizing the company's unique American technology that meets the growing demands of the commercial LEU and HALEU markets, highlighting its strategic importance in national security.
- Strong Backlog: As of the end of Q1, Centrus reported a backlog of $3.9 billion extending through 2040, indicating robust market positioning as the company has contractually produced over 1.6 metric tons of HALEU UF6 under its operations contract, enhancing its competitive edge.
- Cost Savings and Partnerships: Since late January, Centrus has identified approximately $300 million in potential cost savings and formed partnerships with Fluor and Palantir, aimed at reducing manufacturing lead times and accelerating project timelines, thereby improving operational efficiency.
- Revenue Guidance Increase for 2026: Centrus raised its full-year 2026 revenue guidance to $450 million to $500 million from the previous range of $425 million to $475 million, reflecting the company's positive commercial progress and ongoing discussions regarding potential new enrichment offtake contracts.
See More
Update on Domestic Uranium Development: Eagle Nuclear Energy (NASDAQ: NUCL) Begins Pre-Drill Environmental Baseline Studies at Aurora Project
Domestic Uranium Development Update: Eagle Nuclear Energy (NASDAQ: NUCL) has initiated pre-drill environmental baseline studies at the Auroral project site.
Environmental Studies: The studies are aimed at assessing the environmental conditions prior to drilling activities, ensuring compliance with regulatory standards.
See More
Centrus Energy Reports Q1 2026 Financial Results with Strategic Expansion Plans
- Net Income Decline: Centrus Energy reported a net income of $10 million for Q1 2026, a 63% decrease from the same period in 2025, primarily due to a $15.9 million increase in advanced technology costs, indicating financial pressures during expansion.
- Revenue Growth: The company generated total revenue of $76.7 million, a 5% increase from 2025, with the Technical Solutions segment seeing a 47% rise, reflecting strong market demand for technology services and potential for enhanced profitability.
- Cost Control Effectiveness: The cost of sales for the LEU segment decreased by 17% to $16.7 million, partially offsetting the rise in unit costs, demonstrating effective cost management that aids in improving overall profit margins.
- Strong Backlog: As of March 31, 2026, the company's backlog reached $3.9 billion, expected to extend to 2040, indicating a stable revenue source for the coming years and bolstering market confidence.
See More
Centrus Energy Set to Announce Q1 Earnings
- Earnings Announcement Date: Centrus Energy (LEU) is set to release its Q1 earnings on May 5th after market close, with consensus EPS estimated at $0.27 and revenue expected to reach $78.33 million, reflecting a 7.2% year-over-year growth.
- Performance Expectations: Over the past year, Centrus has exceeded EPS estimates 75% of the time and revenue estimates 50% of the time, indicating a degree of stability in its earnings performance amidst market fluctuations.
- Strategic Partnerships: Centrus has partnered with Palantir to expand its U.S. uranium enrichment operations, aiming for $300 million in cost savings, which is expected to enhance the company's competitive position in the energy sector.
- Market Sentiment and Ratings: While the market remains cautious about Centrus's future performance, analysts express optimism regarding potential growth in the nuclear energy sector, suggesting that the company's valuation may present risks that require careful investment consideration.
See More
Oklo's Stock Volatility and Future Outlook
- Stock Volatility: Oklo experienced a remarkable 238% gain in 2025, yet has seen a 15% decline in 2026, indicating investor concerns about its current valuation and future prospects, necessitating careful evaluation before investing.
- Collaborative Projects: The partnership with Meta to develop a 1.2GW nuclear energy campus involves deploying multiple Aurora reactors, but the lack of Nuclear Regulatory Commission approval raises questions about the project's feasibility and timeline.
- Fuel Supply Challenges: The Aurora reactors require high-assay low-enriched uranium (HALEU), which is currently in short supply in the U.S., with only 0.9 metric tons delivered in 2025, potentially hindering the commercialization timeline.
- Future Risks: With commercialization expected by 2027 or 2028, Oklo faces execution risks and market volatility, making it crucial for investors to weigh its long-term potential against short-term uncertainties.
See More
Centrus Energy Reports Decline in Q1 Profit
- Profit Decline: Centrus Energy reported a first-quarter net profit of $10 million, or $0.45 per share, which represents a significant drop from last year's $27.2 million and $1.60 per share, indicating a notable weakening in the company's profitability.
- Adjusted Earnings: Excluding special items, Centrus reported adjusted earnings of $23.5 million, or $1.05 per share, which, while lower than last year, still demonstrates some resilience in earnings performance amidst challenging conditions.
- Revenue Growth: The company's revenue for the first quarter rose by 4.9% to $76.7 million, up from $73.1 million last year, suggesting that the business has managed to maintain a degree of growth despite the profit decline.
- Full-Year Revenue Guidance: Centrus has provided full-year revenue guidance of $450 million to $500 million, reflecting a cautiously optimistic outlook for future revenue growth, despite the current profit decline, indicating management's confidence in market demand.
See More
Centrus Energy Corp. Q1 2026 Earnings Call Highlights
- Historic Expansion Launch: Centrus initiated its historic project to return the U.S. to domestic commercial uranium enrichment in Q1 2026, with CEO Amir Vexler emphasizing the company's unique American technology that meets the growing demands of the commercial LEU and HALEU markets, highlighting its strategic importance in national security.
- Strong Backlog: As of the end of Q1, Centrus reported a backlog of $3.9 billion extending through 2040, indicating robust market positioning as the company has contractually produced over 1.6 metric tons of HALEU UF6 under its operations contract, enhancing its competitive edge.
- Cost Savings and Partnerships: Since late January, Centrus has identified approximately $300 million in potential cost savings and formed partnerships with Fluor and Palantir, aimed at reducing manufacturing lead times and accelerating project timelines, thereby improving operational efficiency.
- Revenue Guidance Increase for 2026: Centrus raised its full-year 2026 revenue guidance to $450 million to $500 million from the previous range of $425 million to $475 million, reflecting the company's positive commercial progress and ongoing discussions regarding potential new enrichment offtake contracts.
See More
Update on Domestic Uranium Development: Eagle Nuclear Energy (NASDAQ: NUCL) Begins Pre-Drill Environmental Baseline Studies at Aurora Project
Domestic Uranium Development Update: Eagle Nuclear Energy (NASDAQ: NUCL) has initiated pre-drill environmental baseline studies at the Auroral project site.
Environmental Studies: The studies are aimed at assessing the environmental conditions prior to drilling activities, ensuring compliance with regulatory standards.
See More
Centrus Energy Reports Q1 2026 Financial Results with Strategic Expansion Plans
- Net Income Decline: Centrus Energy reported a net income of $10 million for Q1 2026, a 63% decrease from the same period in 2025, primarily due to a $15.9 million increase in advanced technology costs, indicating financial pressures during expansion.
- Revenue Growth: The company generated total revenue of $76.7 million, a 5% increase from 2025, with the Technical Solutions segment seeing a 47% rise, reflecting strong market demand for technology services and potential for enhanced profitability.
- Cost Control Effectiveness: The cost of sales for the LEU segment decreased by 17% to $16.7 million, partially offsetting the rise in unit costs, demonstrating effective cost management that aids in improving overall profit margins.
- Strong Backlog: As of March 31, 2026, the company's backlog reached $3.9 billion, expected to extend to 2040, indicating a stable revenue source for the coming years and bolstering market confidence.
See More
Centrus Energy Set to Announce Q1 Earnings
- Earnings Announcement Date: Centrus Energy (LEU) is set to release its Q1 earnings on May 5th after market close, with consensus EPS estimated at $0.27 and revenue expected to reach $78.33 million, reflecting a 7.2% year-over-year growth.
- Performance Expectations: Over the past year, Centrus has exceeded EPS estimates 75% of the time and revenue estimates 50% of the time, indicating a degree of stability in its earnings performance amidst market fluctuations.
- Strategic Partnerships: Centrus has partnered with Palantir to expand its U.S. uranium enrichment operations, aiming for $300 million in cost savings, which is expected to enhance the company's competitive position in the energy sector.
- Market Sentiment and Ratings: While the market remains cautious about Centrus's future performance, analysts express optimism regarding potential growth in the nuclear energy sector, suggesting that the company's valuation may present risks that require careful investment consideration.
See More
Oklo's Stock Volatility and Future Outlook
- Stock Volatility: Oklo experienced a remarkable 238% gain in 2025, yet has seen a 15% decline in 2026, indicating investor concerns about its current valuation and future prospects, necessitating careful evaluation before investing.
- Collaborative Projects: The partnership with Meta to develop a 1.2GW nuclear energy campus involves deploying multiple Aurora reactors, but the lack of Nuclear Regulatory Commission approval raises questions about the project's feasibility and timeline.
- Fuel Supply Challenges: The Aurora reactors require high-assay low-enriched uranium (HALEU), which is currently in short supply in the U.S., with only 0.9 metric tons delivered in 2025, potentially hindering the commercialization timeline.
- Future Risks: With commercialization expected by 2027 or 2028, Oklo faces execution risks and market volatility, making it crucial for investors to weigh its long-term potential against short-term uncertainties.
See More
